Peoplesway.com Inc.
Peoplesway.com Inc.
Your view on PLWY
Overview
What the company does, where it operates, and who runs it.
About Peoplesway.com Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Matthew Monroe
- Headquarters
- 2969 Interstate Street, Charlotte, NC, US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Matthew Monroe
- Headquarters
- 2969 Interstate Street, Charlotte, NC, US
Peoplesway.com Inc. develops and sells wellness products. It offers weight management, pain relief, skincare, and bio-identical hormone replacement products, as well as supplements.
The company provides Pro-HM, a solution for hormonal imbalances in women; Pro-MC, a hormonal product for men; ProTec, an antioxidant supplement for protection against free radicals that destroy cells; and ProTrim, a dietary supplement.
It also offers Oil of Mink that prevent fine lines and wrinkles in men and women; and Pro-GCM Plus and Pro-GCM, which are joint protection products. The company also sells its products online. Peoplesway.com Inc. was founded in 1980 and is headquartered in Charlotte, North Carolina.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Peoplesway.com Inc., and the rating behind it. PLWY last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Peoplesway.com Inc.. Starting points for Peoplesway.com Inc.: EPS -$0.02, beta 5.34 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Peoplesway.com Inc.. Peoplesway.com Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Peoplesway.com Inc.. Trailing twelve-month EPS for Peoplesway.com Inc. stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Peoplesway.com Inc.. Peoplesway.com Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peoplesway.com Inc. valued side by side against its closest peers. Peoplesway.com Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Peoplesway.com Inc., and how their positions are changing. At a $1,508 market value, institutional positions materially move Peoplesway.com Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Peoplesway.com Inc. executives and directors. Shares of Peoplesway.com Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Peoplesway.com Inc.. Peoplesway.com Inc. is a $1,508 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Peoplesway.com Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Peoplesway.com Inc.. Coverage tracks Peoplesway.com Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.